Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

100023

	registered interest
	date	15/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ovarian Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to increase early identification of ovarian cancer.
	tabling member constituency	Washington and Sunderland West
	tabling member printed	Mrs Sharon Hodgson
	uin	905561
	answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>We are investing £450 million in earlier diagnosis of cancer, including improving direct general practitioner access to non-obstetric ultrasound to support earlier diagnosis of ovarian cancer.</p><p> </p><p> </p><p> </p><p>Public Health England ran a regional Be Clear on Cancer campaign early in 2014 to raise awareness of the symptoms of ovarian cancer. The findings of the pilot will be evaluated in 2015, and this evidence would inform any decision to move from a regional to national campaign.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/10/2014 15:46:38 answering member 3918 label Biography information for Jane Ellison
	tabling member	1521 label Biography information for Mrs Sharon Hodgson

47268

	registered interest
	date	07/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether funding allocated to Action on Smoking and Health may be used for campaigning purposes by that body under the terms on which it is allocated.
	tabling member constituency	Shipley
	tabling member printed	Philip Davies
	uin	195596
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Since 2011, the conditions for the grants provided to Action on Smoking and Health under the Department of Health's “Section 64 General Scheme of Grants to voluntary and Community Organisations” arrangements have explicitly set out that none of the funding provided by the Department should be intended or used for political lobbying or campaigning purposes.</p><p> </p><p>Advocacy work in support of the implementation of existing Government Tobacco Control policies and programmes of work is acceptable.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	1565 label Biography information for Sir Philip Davies

48240

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what progress his Department has made on diagnosis rates of brain tumours in the last 10 years; and if he will make a statement.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196261
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p><em>Improving Outcomes: A Strategy for Cancer</em>, published on 12 January 2011, stated that general practitioners (GPs) need easy access to the right diagnostic tests to diagnose or exclude cancer earlier. The strategy committed over £450 million over four years, to achieve early diagnosis of cancer, including improving access to key diagnostic tests, such as Magnetic Resonance Imaging (MRI) scans to support the diagnosis of brain cancer. The funding was also designed to cover subsequent testing and treatment in secondary care.</p><p> </p><p>In 2012, the Department published <em>Direct Access to Diagnostic Tests for Cancer</em>,<em>Best Practice Referral Pathways for General Practitioners. </em>The document includes criteria for accessing key diagnostic tests including MRI brain scan and aims to raise awareness of the symptoms that require urgent referral to specialists and sets out where a direct referral for an MRI brain scan may benefit patients through achieving a faster diagnosis. GPs are able to access these tests directly in cases where the two week urgent referral pathway is not appropriate but a patient's symptoms require further investigation. The intention is that more people presenting with relevant symptoms will be tested and at an earlier stage.</p><p> </p><p>NHS England monitors the use of these diagnostic tests through the Diagnostic Imaging Dataset. Latest provisional data published by NHS England on 27 March 2014 for the period November 2012 to November 2013, showed that over a quarter of all tests that may have been used to diagnose or discount cancer were requested by GPs under direct access arrangements. In that period, 509,215 MRI tests were requested including 35,055 through direct GP access arrangements. The published data is available at:</p><p> </p><p><a href="http://www.england.nhs.uk/statistics/statistical-work-areas/diagnostic-imaging-dataset/diagnostic-imaging-datasetdiagnostic-imaging-dataset-2013-14-data/" target="_blank">www.england.nhs.uk/statistics/statistical-work-areas/diagnostic-imaging-dataset/diagnostic-imaging-datasetdiagnostic-imaging-dataset-2013-14-data/</a>.</p><p> </p><p>Information on diagnosis rates of brain tumours is not centrally collected. Information on number of patients with suspected brain or central nervous system tumours who were seen by a specialist within two weeks from a GP referral is provided in the attached tables, for the last 10 years.</p><p> </p><p>Before 2009, the operational standard for two week waits was 98%. Starting from the 1 of January 2009, the basis for reporting waiting times data was changed. The new standards were set to be more in line with the already implemented referral to treatment routes. The scope of cover for the new standards was widened (as set out in the Cancer Reform Strategy 2008), and the collection was made simpler by not using clock pauses. From 2009 onwards the operational standard for two week waits was set to 93% (assumed to be the maximum sustainable performance level) including tolerances for:</p><p>- The number of patients who make themselves unavailable or decline an appointment within two weeks.</p><p>- Patients who cancel a booked outpatient appointment (giving advance notice), and rebook appointments outside of 14-days.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196258 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison attachment 1 file name No of patients with suspected brain or central nervous system tumours.docx title Tables for PQs 196258 and 196261
	tabling member	3950 label Biography information for Dame Tracey Crouch

48245

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the sufficiency of access to imagery scanning for diagnosing brain tumours; and if he will issue revised guidance on when to refer a patient for a scan with the aim of raising diagnosis rates and decreasing mortality rates.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196258
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p><em>Improving Outcomes: A Strategy for Cancer</em>, published on 12 January 2011, stated that general practitioners (GPs) need easy access to the right diagnostic tests to diagnose or exclude cancer earlier. The strategy committed over £450 million over four years, to achieve early diagnosis of cancer, including improving access to key diagnostic tests, such as Magnetic Resonance Imaging (MRI) scans to support the diagnosis of brain cancer. The funding was also designed to cover subsequent testing and treatment in secondary care.</p><p> </p><p>In 2012, the Department published <em>Direct Access to Diagnostic Tests for Cancer</em>,<em>Best Practice Referral Pathways for General Practitioners. </em>The document includes criteria for accessing key diagnostic tests including MRI brain scan and aims to raise awareness of the symptoms that require urgent referral to specialists and sets out where a direct referral for an MRI brain scan may benefit patients through achieving a faster diagnosis. GPs are able to access these tests directly in cases where the two week urgent referral pathway is not appropriate but a patient's symptoms require further investigation. The intention is that more people presenting with relevant symptoms will be tested and at an earlier stage.</p><p> </p><p>NHS England monitors the use of these diagnostic tests through the Diagnostic Imaging Dataset. Latest provisional data published by NHS England on 27 March 2014 for the period November 2012 to November 2013, showed that over a quarter of all tests that may have been used to diagnose or discount cancer were requested by GPs under direct access arrangements. In that period, 509,215 MRI tests were requested including 35,055 through direct GP access arrangements. The published data is available at:</p><p> </p><p><a href="http://www.england.nhs.uk/statistics/statistical-work-areas/diagnostic-imaging-dataset/diagnostic-imaging-datasetdiagnostic-imaging-dataset-2013-14-data/" target="_blank">www.england.nhs.uk/statistics/statistical-work-areas/diagnostic-imaging-dataset/diagnostic-imaging-datasetdiagnostic-imaging-dataset-2013-14-data/</a>.</p><p> </p><p>Information on diagnosis rates of brain tumours is not centrally collected. Information on number of patients with suspected brain or central nervous system tumours who were seen by a specialist within two weeks from a GP referral is provided in the attached tables, for the last 10 years.</p><p> </p><p>Before 2009, the operational standard for two week waits was 98%. Starting from the 1 of January 2009, the basis for reporting waiting times data was changed. The new standards were set to be more in line with the already implemented referral to treatment routes. The scope of cover for the new standards was widened (as set out in the Cancer Reform Strategy 2008), and the collection was made simpler by not using clock pauses. From 2009 onwards the operational standard for two week waits was set to 93% (assumed to be the maximum sustainable performance level) including tolerances for:</p><p>- The number of patients who make themselves unavailable or decline an appointment within two weeks.</p><p>- Patients who cancel a booked outpatient appointment (giving advance notice), and rebook appointments outside of 14-days.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196261 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison attachment 1 file name No of patients with suspected brain or central nervous system tumours.docx title Tables for PQs 196258 and 196261
	tabling member	3950 label Biography information for Dame Tracey Crouch

48246

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to encourage international collaboration in research and the sharing of best practice on quality of life for patients diagnosed with brain tumours.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196259
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>NHS England has made a recent assessment of the sufficiency of access to information about support and services for people diagnosed with a brain tumour through its Peer Review Programme (PRP). This programme includes measures that require all brain and central nervous system multidisciplinary teams (MDTs) to demonstrate the availability and adequacy of patient information. The outcome of the 2013-14 assessment of compliance with these measures indicated that out of 91 MDTs and 36 treatment centres, 84% were compliant with the patient information measure at the most robust level.</p><p> </p><p>There is a programme of work aimed at improving the care and experience of people living with a diagnosis of cancer, developed in collaboration with Macmillan Cancer Support which draws from a wide range of evidence based good practice.</p><p> </p><p>The National Cancer Intelligence Network runs a brain and central nervous system- related cancers Clinical Reference Group, which works closely with a brain cancer charities. In addition to this, the PRP measures participation in drug trials and research internationally.</p><p> </p><p>The Department works closely with its cancer research funding partners through the National Cancer Research Institute (NCRI). The NCRI is a strategic partnership of 22 government, charity and industry cancer research funders, together with patients. The NCRI is a member of the International Cancer Research Partnership (ICRP), which includes cancer research funders from USA, Canada, Europe, Japan and Australia. The ICRP is a unique alliance of cancer organisations working together to enhance global collaboration and strategic coordination of research. Researchers can search the ICRP database to avoid duplication and identify collaborators in specific areas of cancer research including brain tumour research.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196257 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3950 label Biography information for Dame Tracey Crouch

48248

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the sufficiency of access to information about support and services for people diagnosed with a brain tumour; and if he will make a statement.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196257
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>NHS England has made a recent assessment of the sufficiency of access to information about support and services for people diagnosed with a brain tumour through its Peer Review Programme (PRP). This programme includes measures that require all brain and central nervous system multidisciplinary teams (MDTs) to demonstrate the availability and adequacy of patient information. The outcome of the 2013-14 assessment of compliance with these measures indicated that out of 91 MDTs and 36 treatment centres, 84% were compliant with the patient information measure at the most robust level.</p><p> </p><p>There is a programme of work aimed at improving the care and experience of people living with a diagnosis of cancer, developed in collaboration with Macmillan Cancer Support which draws from a wide range of evidence based good practice.</p><p> </p><p>The National Cancer Intelligence Network runs a brain and central nervous system- related cancers Clinical Reference Group, which works closely with a brain cancer charities. In addition to this, the PRP measures participation in drug trials and research internationally.</p><p> </p><p>The Department works closely with its cancer research funding partners through the National Cancer Research Institute (NCRI). The NCRI is a strategic partnership of 22 government, charity and industry cancer research funders, together with patients. The NCRI is a member of the International Cancer Research Partnership (ICRP), which includes cancer research funders from USA, Canada, Europe, Japan and Australia. The ICRP is a unique alliance of cancer organisations working together to enhance global collaboration and strategic coordination of research. Researchers can search the ICRP database to avoid duplication and identify collaborators in specific areas of cancer research including brain tumour research.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196259 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3950 label Biography information for Dame Tracey Crouch

48257

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the performance of cancer services against statements 11 and 12 in the National Institute for Health and Care Excellence Breast cancer quality standard.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	196367
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to National Institute for Health and Care Excellence (NICE) Quality Standards. Commissioners should have regard to them in the planning of services they commission according to their population needs.</p><p> </p><p>Whilst no assessment has been made of the performance of services against the Breast Cancer Quality Standard, compliance with Quality Standards generally could be monitored through a range of mechanisms depending on the specific Quality Standard. For example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the Clinical Commissioning Group Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using Quality Standards where appropriate.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and Quality Standards. The new national clinical audit will be in place by the end of 2014-15.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196363 196365 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3924 label Biography information for Yasmin Qureshi

48258

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what methods of data collection his Department uses to measure the performance of services against each of the 13 statements in the National Institute for Health and Care Excellence Breast cancer quality standard.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	196365
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to National Institute for Health and Care Excellence (NICE) Quality Standards. Commissioners should have regard to them in the planning of services they commission according to their population needs.</p><p> </p><p>Whilst no assessment has been made of the performance of services against the Breast Cancer Quality Standard, compliance with Quality Standards generally could be monitored through a range of mechanisms depending on the specific Quality Standard. For example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the Clinical Commissioning Group Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using Quality Standards where appropriate.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and Quality Standards. The new national clinical audit will be in place by the end of 2014-15.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196363 196367 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3924 label Biography information for Yasmin Qureshi

48259

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment his Department has made of the overall performance of cancer services against the National Institute for Health and Care Excellence Breast cancer quality standard.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	196363
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to National Institute for Health and Care Excellence (NICE) Quality Standards. Commissioners should have regard to them in the planning of services they commission according to their population needs.</p><p> </p><p>Whilst no assessment has been made of the performance of services against the Breast Cancer Quality Standard, compliance with Quality Standards generally could be monitored through a range of mechanisms depending on the specific Quality Standard. For example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the Clinical Commissioning Group Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using Quality Standards where appropriate.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and Quality Standards. The new national clinical audit will be in place by the end of 2014-15.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196365 196367 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3924 label Biography information for Yasmin Qureshi

48261

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that future iterations of the Cancer Patient Experience Survey enable the responses of patients with primary and secondary cancer to be analysed separately.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	196364
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>No recent Ministerial discussions have taken place on the potential for Patient Reported Outcome Measures to be used to measure improvements in outcomes for breast cancer patients.</p><p><strong> </strong></p><p>NHS England took over responsibility for the Cancer Patient Experience Survey (CPES) on 1 April 2013. The development of the CPES is overseen by the Cancer Patient Experience Advisory Group (CPEAG), which has a wide ranging membership including clinicians, cancer charities, experts in survey methodologies, research bodies, health service commissioners and NHS England staff.</p><p> </p><p>The survey questionnaire is reviewed by CPEAG each year to ensure that it captures the best information and as part of the process for the next survey, NHS England is engaging with a range of stakeholders to look at how it can improve and amend the survey appropriately.</p><p> </p><p>In the meantime, NHS England has added a new question to the 2014 survey questionnaire to identify patients who have been diagnosed with cancer more than once because the evidence suggests that there may be a difference in the experience of those patients.</p><p> </p><p>The results of the 2014 survey will be published later this year.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196366 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3924 label Biography information for Yasmin Qureshi